“… 24 , 25 , 26 In patients with migraine, a meta-analysis of three small trials concluded that prophylactic melatonin use reduced the frequency, severity, and duration of migraine compared with placebo but was not superior to amitriptyline. 27 A recent meta-analysis of four small trials showed reduced severity of irritable bowel syndrome after variable durations of melatonin treatment, although sleep was not improved. 28 The doses of melatonin used in these studies were variable; there is no consensus as to what constitutes a clinically effective dose.…”